Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136313 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ding Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIF…. Hauptthemen laut MEDLINE: HIV Infections, Epitopes, AIDS Vaccines, Viral Vaccines. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
In the current global health environment, the spread of the monkeypox virus (MPXV) and the persistent threat of human immunodeficiency virus (HIV) have become critical public health challenges. Since 2022, MPXV has rapidly disseminated worldwide, and nearly half of MPXV-infected individuals are co-infected with HIV. This complex situation calls for innovative preventive strategies. In this study, an innovative multi-epitope vaccine was designed using bioinformatics and immunoinformatic approaches. Ten HIV proteins and nine MPXV proteins were used to predict potential epitopes. Non-allergenic, highly antigenic, IFN-γ-inducible, and non-toxic epitopes were selected to construct the multi-epitope vaccine. It was found that the designed vaccine construct was highly antigenic, soluble, and had acceptable physicochemical properties. Based on molecular docking and molecular dynamics simulation (MDs) analyses, the vaccine construct demonstrated stable and robust interactions with Toll-like receptors (TLR2, TLR3, and TLR4). Although no actual animal experiments have been conducted to evaluate the vaccine’s effectiveness, immune simulations showed that the vaccine could elicit potent humoral and cell-mediated immune responses. Overall, this study provides a promising vaccine candidate against MPXV and HIV co-infection and emphasizes innovative strategies to interrupt the international transmission of these two viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
- Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming 650118, China.
ORCID-Profile: Ding Tang, Weijin Huang
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Tang, D., Wu, S., Wang, Y., & Huang, W. (2025). Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136313
Vancouver
Tang D, Wu S, Wang Y, Huang W. Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136313
BibTeX
@article{Tang2025,
author = {Tang, Ding and Wu, Siwen and Wang, Youchun and Huang, Weijin},
title = {Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136313}
}
EUVIMED